NEWS AND EVENTS
With the evolution of sophisticated protein therapeutics, new challenges are emerging to make these molecules faster and in a functional form.
PRESS RELEASES
2009
08/20/2009 - Sutro Biopharma Announces Additions to Board of Directors and Senior Management Team.
Read more
Read more
06/09/2009 - Sutro Biopharma Adds to Extensive IP Portfolio with Two Newly Issued Patents and Two Patent Grant Notices. Covers the Only Cell-Free Synthesis Platform Applicable to Protein Discovery Through Production.
Read more
Read more
03/30/2009 - Sutro Biopharma Hits Major Technical Milestone, Reaching 100 Liter Scale for the Company’s Open Cell-free Protein Synthesis Technology. Milestone Triggers $15 Million Series B Financing.
Read more
Read more
01/12/2009 - William J. Newell Named Chief Executive Officer of Sutro Biopharma. Former CEO Daniel S. Gold, Ph.D. Becomes President and Chief Operating Officer. Company Notes Name Change from Fundamental Applied Biology and Relocation to South San Francisco.
Read more
Read more
2008
01/16/2008 - Fundamental Applied Biology, Inc. Is Awarded NSF SBIR Phase IIB Grant for the Commercialization of Protein Therapeutics Using Cell-Free Technology
Read more
Read more
2007
12/10/2007 - Fundamental Applied Biology, Inc. Completes $21 Million Series B Financing. Daniel S. Gold, PhD, Joins as Chief Executive Officer
Read more
Read more
News and Publications
06/2010 - Learn more ! Sutro Biopharma Corporate Presentation PDF file available here...
Read more
Read more
12/2009 - National Science Foundation (NSF) newsletter featuring Sutro Biopharma and Promising Protein Synthesis Technology
Read more
Read more
10/2009 - IBC Bioprocess International Conference and Exhibition, Raleigh, NC. - Cell Free Productin of Pharmaceutical Proteins
Read more
Read more
06/2009 - Sutro Biopharma Inc. - Profile
Read more
Read more
| Site Map
